Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …

Acute leukemias (both myeloid and lymphoblastic) are a group of diseases for which each
year more successful therapies are implemented. However, in a subset of cases the overall …

Relapse has emerged as the most important cause of treatment failure after allogeneic
hematopoietic stem cell transplantation (HSCT). To test the hypothesis that natural killer …

Background The use of post-transplant cyclophosphamide (PTCy) is highly effective in
preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting …

Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in
patients receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments …

Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the treatment of
choice to consolidate remission in patients with poor-risk acute myeloid leukemia (AML) …

Allogeneic stem cell transplantation with HLA-matched donors is increasingly used for older
patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It …

The optimal conditioning regimen for older patients with acute myeloid leukemia (AML)
remains unclear. In this study, we compared outcomes of AML patients> 60 years of age …

PURPOSE There is no consensus on the best choice of an alternative donor (umbilical cord
blood [UCB], haploidentical, one-antigen mismatched [7/8]–bone marrow [BM], or 7/8 …

Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of
haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD) …